SYNER-KINASE

This brand name is authorized in Malta, United Kingdom

Active ingredients

The drug SYNER-KINASE contains one active pharmaceutical ingredient (API):

1 Urokinase UNII 83G67E21XI - UROKINASE

Urokinase is a highly purified form of naturally occurring human urokinase extracted from urine. It is a thrombolytic agent which converts plasminogen into plasmin (fibrinolysin) a proteolytic enzyme that breaks down fibrin as well a fibrinogen and other plasma proteins. Read about Urokinase

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SYNER-KINASE Powder for solution for injection or infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AD04	Urokinase	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes
Discover more medicines within B01AD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 110213, 110217, 115429, 115431, 202598
Country: MT	Medicines Authority	Identifier(s): AA565/32102